PeerJ (Feb 2020)
Prognostic analysis of very early onset pancreatic cancer: a population-based analysis
Abstract
Background We aimed to use competing risk model to assess whether very early onset pancreatic cancer (VEOPC ) (79 years). There was no significant prognostic difference between VEOPC and each older group in resectablePDAC. Our competing nomogram showed well discrimination and calibration by internal validation. Conclusion For unresectable PDAC patients, VEOPC had better CSS than older patients. Our competing risk nomogram might be an easy-to-use tool for the specific death prediction of VEOPC patients with PDAC.
Keywords